Adjuvant treatment of in-transit melanoma: narrowing the knowledge gap left by clinical trials

Meza, M.M. de; Blokx, W.A.M.; Bonenkamp, H.J.; Blank, C.U.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; ... ; Wouters, M.W.J.M. (2023)

Article / Letter to editor

• adjuvant treatment
• melanoma
• checkpoint inhibition therapy
• immunotherapy
• in-transit melanoma

• All authors: Meza, M.M. de; Blokx, W.A.M.; Bonenkamp, H.J.; Blank, C.U.; Aarts, M.J.B.; Berkmortel, F.W.P.J. van den; Boers-Sonderen, M.J.; Groot, J.W.B. de; Haanen, J.B.; Hospers, G.A.P.; Kapiteijn, E.W.; Not, O.J. van; Piersma, D.; Rijn, R.S. van; Boer, M.A.S.D.; Veldt, A.A.M. van der; Vreugdenhil, G.; Eertwegh, A.J.M. van den; Suijkerbuijk, K.P.M.; Wouters, M.W.J.M.
• Date: 2023-03-08
• Journal: International Journal of Cancer
• Volume: 153
• Issue: 2
• Pages: 389 - 398
• DOI: doi:10.1002/ijc.34485